Bharat Immunologicals Selected Fundamentals

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Current Valuation Analysis

Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bharat Immunologicals 
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
 = 
862.5 M

About Current Valuation

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has Current Valuation of 862.5 M. This is much higher than that of the sector, and significantly higher than that of Current Valuation industry, The Current Valuation for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in gross profit category among related companies. It is rated below average in price to sales category among related companies . The ratio of Gross Profit to Price to Sales for Bharat Immunologicals Biologicals Corp Ltd is about  180,303,030 

Peer Comparison

Bharat Immunologicals EBITDA Comparison
Bharat Immunologicals is currently under evaluation in ebitda category among related companies.

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
Hide  View All  Next  Launch Volatility Analysis

Fundamental Indicators

Current Bharat Immunologicals financial ratios